Search PDMR transactions

Notifier
Name
Per Wold-Olsen
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Per Wold-Olsen
Position
Chairman of the Board
Initial notification
Yes
Amendment
No
Details of amendment
Issuer
Name of issuer
Oncopeptides AB publ.
LEI code
549300J9WWQ5CBYQ1M77
Details of transaction
Financial instrument ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Trading venue
Oncopeptides AB SE0009414576 Acquisition 200 Quantity 103.80 SEK 18/05/2018 NASDAQ STOCKHOLM AB
Oncopeptides AB SE0009414576 Acquisition 650 Quantity 104.00 SEK 18/05/2018 NASDAQ STOCKHOLM AB
Oncopeptides AB SE0009414576 Acquisition 2 Quantity 104.00 SEK 18/05/2018 NASDAQ STOCKHOLM AB
Oncopeptides AB SE0009414576 Acquisition 1,000 Quantity 104.40 SEK 18/05/2018 NASDAQ STOCKHOLM AB
Oncopeptides AB SE0009414576 Acquisition 433 Quantity 104.40 SEK 18/05/2018 NASDAQ STOCKHOLM AB
Oncopeptides AB SE0009414576 Acquisition 250 Quantity 104.60 SEK 18/05/2018 NASDAQ STOCKHOLM AB
Oncopeptides AB SE0009414576 Acquisition 406 Quantity 104.80 SEK 18/05/2018 NASDAQ STOCKHOLM AB
Oncopeptides AB SE0009414576 Acquisition 325 Quantity 104.80 SEK 18/05/2018 NASDAQ STOCKHOLM AB
Oncopeptides AB SE0009414576 Acquisition 1,500 Quantity 105.00 SEK 18/05/2018 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Trading venue Volume Weighted average price
Oncopeptides AB SE0009414576 Acquisition 18/05/2018 NASDAQ STOCKHOLM AB 4,766 (Quantity) 104.58078053 SEK
Total: 4,766
<< Back